DXP Enterprises, Inc. Reports Second Quarter 2025 Results
$498.7 million in sales, a 4.6 percent sequential and 11.9 percent year-over-year increase
GAAP diluted EPS of $1.43
$57.3 million in earnings before interest, taxes, depreciation & amortization and other non-cash charges ("Adjusted EBITDA")
Completed two acquisitions through Q2 and one subsequent to quarter end
HOUSTON, August 06, 2025--(BUSINESS WIRE)--DXP Enterprises, Inc. ("DXP" or the "Company") (NASDAQ: DXPE) today announced financial results for the second quarter ended June 30, 2025. The following are results for the three months ended June 30, 2025, compared to the three months ended June 30, 2024, and March 31, 2025, where appropriate. A reconciliation of the non-GAAP financial measures can be found in the back of this press release.
Second Quarter 2025 Financial Highlights:
Sales increased 11.9 percent to $498.7 million compared to $445.6 million for the second quarter of 2024 and increased 4.6 percent sequentially from $476.6 million for the first quarter of 2025.
Net income increased 41.3 percent for the second quarter to $23.6 million, compared to $16.7 million for the second quarter of 2024 and $20.6 million for the first quarter of 2025.
Earnings per diluted share for the second quarter was $1.43 based upon 16.5 million diluted shares, compared to $1.00 earnings per diluted share in the second quarter of 2024, based on 16.7 million diluted shares.
Adjusted EBITDA for the second quarter was $57.3 million compared to $48.2 million for the second quarter of 2024 and $52.5 million for the first quarter of 2025. Adjusted EBITDA as a percentage of sales, or Adjusted EBITDA margin, was 11.5 percent, 10.8 percent, and 11.0 percent, respectively.
Cash flow from operating activities increased 26.5 percent for the second quarter to $18.6 million, compared to $14.7 million for the second quarter of 2024.
Free Cash Flow (cash flow from operating activities less capital expenditures) for the second quarter was $8.3 million, compared to $5.9 million for second quarter of 2024.
Business segment financial highlights:
Service Centers' revenue for the second quarter was $339.7 million, an increase of 10.8 percent year-over-year, with a 14.8 percent operating income margin.
Innovative Pumping Solutions' revenue for the second quarter was $93.5 million, an increase of 27.5 percent year-over-year, with a 19.9 percent operating income margin.
Supply Chain Services' revenue for the second quarter was $65.4 million, a decrease of 0.4 percent year-over-year, with a 8.0 percent operating income margin.
David R. Little, Chairman and Chief Executive Officer commented, "Second quarter results reflect the execution of our growth strategy and the resilience and durability of DXP's business. We are pleased with our sequential and year-over-year sales growth and strength in our gross profit margins. This resulted in operating leverage that produced earnings per share of $1.43. DXP's second quarter 2025 sales were $498.7 million, or a 4.6 percent increase over the first quarter of 2025 and 11.9 percent increase over 2024. Sequential organic sales for the quarter increased 12.3 percent or $51.9 million and acquisitions added another $24.6 million in sales during Q2. Adjusted EBITDA grew $4.8 million, or 9.2 percent over the first quarter of 2025. During the second quarter of 2025, sales were $339.7 million for Service Center, $93.5 million for Innovative Pumping Solutions, and $65.4 million for Supply Chain Services. Overall, we are very pleased with our performance and the progress DXP continues to make as a growth company, and we are excited to enter the second half of 2025."
Kent Yee, Chief Financial Officer and Senior Vice President, remarked, "DXP achieved another high watermark quarter with a 4.6 percent sequential and 11.9 percent year-over-year sales increase to $498.7 million and 11.5 percent Adjusted EBITDA margins. We have closed two acquisitions through the second quarter, and one subsequent, and we anticipate closing at least three or four more acquisitions during the second half of 2025. This quarters financial results reflect continued execution of our strategic goals and the impact of our diversification efforts, an overall reduced energy industry exposure, and a strong balance sheet to support our key initiatives. Total debt outstanding as of June 30, 2025, was $626.8 million. DXP's secured leverage ratio or net debt to EBITDA ratio was 2.4:1.0 with a covenant EBITDA of $221.1 million for the last twelve months ending June 30, 2025."
Conference Call Information
DXP Enterprises, Inc. management will host a conference call, August 7, 2025, at 10:30 a.m. Central Time, to discuss the Company's financial results. The conference call may be accessed by going to https://ir.dxpe.com.
Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at https://ir.dxpe.com. The online replay will be available on the same website immediately following the call. A slide presentation highlighting the Company's results and key performance indicators will also be available on the Investor Relations section of the Company's website.
To learn more about DXP Enterprises, Inc., please visit the Company's website at https://www.dxpe.com.
About DXP Enterprises, Inc.
DXP Enterprises, Inc. is a leading products and service distributor that adds value and total cost savings solutions to industrial customers throughout North America and Dubai. DXP provides innovative pumping solutions, supply chain services and maintenance, repair, operating and production ("MROP") services that emphasize and utilize DXP's vast product knowledge and technical expertise in rotating equipment, bearings, power transmission, metal working, industrial supplies and safety products and services. DXP's breadth of MROP products and service solutions allows DXP to be flexible and customer-driven, creating competitive advantages for our customers. DXP's business segments include Service Centers, Innovative Pumping Solutions and Supply Chain Services. For more information, go to www.dxpe.com.
Non-GAAP Financial Measures
DXP supplements reporting of net income with certain non-GAAP measurements, including EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, and Free Cash Flow. This supplemental information should not be considered in isolation or as a substitute for the unaudited GAAP measurements. Additional information regarding EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, Free Cash Flow and net debt referred to in this press release are included below under "Unaudited Reconciliation of Non-GAAP Financial Information".
The Company believes EBITDA provides additional information about: (i) operating performance, because it assists in comparing the operating performance of the business, as it removes the impact of non-cash depreciation and amortization expense as well as items not directly resulting from core operations such as interest expense and income taxes and (ii) the performance and the effectiveness of operational strategies. Additionally, EBITDA performance is a component of a measure of the Company's financial covenants under its credit facilities. Furthermore, some investors use EBITDA as a supplemental measure to evaluate the overall operating performance of companies in the industry. Management believes that some investors' understanding of performance is enhanced by including this non-GAAP financial measure as a reasonable basis for comparing ongoing results of operations. By providing this non-GAAP financial measure, together with a reconciliation to its most directly comparable GAAP financial measure, the Company believes it is enhancing investors' understanding of the business and results of operations, as well as assisting investors in evaluating how well the Company is executing strategic initiatives. Free Cash Flow reconciles to the most directly comparable GAAP financial measure of cash flows from operations as provided below. We believe Free Cash Flow is an important liquidity metric because it measures, during a given period, the amount of cash generated that is available to fund acquisitions, make investments, repay debt obligations, repurchase shares of the Company's common stock, and for certain other activities.
Information Related to Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a "safe-harbor" for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made by or to be made by the Company) contains statements that are forward-looking. These forward-looking statements include, without limitation, those about the Company's expectations regarding the Company's expectations regarding the filing of the Form 10-Q; the description of the anticipated changes in the Company's consolidated balance sheet and the results of operations and the Company's assessment of the impact of such anticipated changes; the Company's business, the Company's future profitability, cash flow, liquidity, and growth. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future; and accordingly, such results may differ from those expressed in any forward-looking statement made by or on behalf of the Company. These risks and uncertainties include, but are not limited to: the effectiveness of management's strategies and decisions; our ability to implement our internal growth and acquisition growth strategies; general economic and business conditions specific to our primary customers; changes in government regulations; our ability to effectively integrate businesses we may acquire; new or modified statutory or regulatory requirements; availability of materials and labor; inability to obtain or delay in obtaining government or third-party approvals and permits; non-performance by third parties of their contractual obligations; unforeseen hazards such as weather conditions, acts of war or terrorist acts and the governmental or military response thereto; cyber-attacks adversely affecting our operations; other geological, operating and economic considerations and declining prices and market conditions, including supply or demand for maintenance, repair and operating products, equipment and service; inability of the Company or its independent auditors to complete the work necessary in order to file the Form 10-Q in the expected time frame; unanticipated changes to the Company's operating results in the Form 10-Q as filed or in relation to prior periods, including as compared to the anticipated changes stated here; unanticipated impact of such changes and its materiality; ability to obtain needed capital, dependence on existing management, leverage and debt service, domestic or global economic conditions, ability to manage changes and the continued health or availability of management personnel and changes in customer preferences and attitudes. In some cases, you can identify forward-looking statements by terminology such as, but not limited to, "may," "will," "should," "intend," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "goal," or "continue" or the negative of such terms or other comparable terminology. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the Securities and Exchange Commission, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
DXP ENTERPRISES, INC. AND SUBSIDIARIESUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS($ thousands, except share amounts)
Three Months Ended June 30,
Six Months Ended June 30,
2025
2024
2025
2024
Sales
$
498,682
$
445,556
$
975,251
$
858,191
Cost of sales
340,869
307,763
667,173
596,516
Gross profit
157,813
137,793
308,078
261,675
Selling, general and administrative expenses
111,827
100,441
221,577
195,192
Income from operations
45,986
37,352
86,501
66,483
Interest expense
14,744
15,384
29,404
30,928
Other income, net
(354
)
(1,035
)
(1,672
)
(3,004
)
Income before income taxes
31,596
23,003
58,769
38,559
Provision for income taxes
7,984
6,310
14,568
10,534
Net income
23,612
16,693
44,201
28,025
Preferred stock dividend
22
22
45
45
Net income attributable to common shareholders
$
23,590
$
16,671
$
44,156
$
27,980
Net income
$
23,612
$
16,693
$
44,201
$
28,025
Foreign currency translation adjustments
2,563
93
2,649
(521
)
Comprehensive income
$
26,175
$
16,786
$
46,850
$
27,504
Earnings per share:
Basic
$
1.50
$
1.05
$
2.81
$
1.75
Diluted
$
1.43
$
1.00
$
2.67
$
1.66
Weighted average common shares outstanding:
Basic
15,694
15,868
15,696
15,998
Diluted
16,534
16,708
16,536
16,838
DXP ENTERPRISES, INC. AND SUBSIDIARIESUNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS($ thousands, except share amounts)
June 30, 2025
December 31, 2024
ASSETS
Current assets:
Cash
$
112,930
$
148,320
Restricted cash
—
91
Accounts receivable, net of allowance of $3,665 and $5,172, respectively
361,393
339,365
Inventories
110,758
103,113
Costs and estimated profits in excess of billings
57,260
50,735
Prepaid expenses and other current assets
41,320
20,250
Total current assets
683,661
661,874
Property and equipment, net
107,207
81,556
Goodwill
461,298
452,343
Other intangible assets, net
78,485
85,679
Operating lease right of use assets, net
60,835
46,569
Other long-term assets
20,908
21,473
Total assets
$
1,412,394
$
1,349,494
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of debt
$
6,595
$
6,595
Trade accounts payable
104,764
103,728
Accrued wages and benefits
37,449
41,650
Customer advances
16,018
13,655
Billings in excess of costs and estimated profits
22,906
12,662
Short-term operating lease liabilities
17,071
14,921
Other current liabilities
40,646
50,773
Total current liabilities
245,449
243,984
Long-term debt, net of unamortized debt issuance costs and discounts
620,239
621,684
Long-term operating lease liabilities
45,402
33,159
Other long-term liabilities
33,212
27,879
Total long-term liabilities
698,853
682,722
Total liabilities
944,302
926,706
Commitments and Contingencies
Shareholders' equity:
Series A preferred stock, $1.00 par value; 1,000,000 shares authorized
1
1
Series B preferred stock, $1.00 par value; 1,000,000 shares authorized
15
15
Common stock, $0.01 par value, 100,000,000 shares authorized; 20,401,857 issued and 15,694,084 outstanding at June 30, 2025 and 20,402,861 issued and 15,695,088 outstanding at December 31, 2024
204
204
Additional paid-in capital
217,982
219,511
Retained earnings
433,826
389,670
Accumulated other comprehensive loss
(30,961
)
(33,610
)
Treasury stock, at cost 4,707,773 and 4,707,773 shares, respectively
(152,975
)
(153,003
)
Total DXP Enterprises, Inc. equity
468,092
422,788
Total liabilities and equity
$
1,412,394
$
1,349,494
SEGMENT DATA($ thousands, unaudited)
Three Months Ended June 30,
Six Months Ended June 30,
Sales
2025
2024
2025
2024
Service Centers
$
339,731
$
306,516
$
666,806
$
594,952
Innovative Pumping Solutions
93,540
73,377
179,722
135,592
Supply Chain Services
65,411
65,663
128,723
127,647
Total Sales
$
498,682
$
445,556
$
975,251
$
858,191
Three Months Ended June 30,
Six Months Ended June 30,
Operating Income
2025
2024
2025
2024
Service Centers
$
50,171
$
43,855
$
97,215
$
84,175
Innovative Pumping Solutions
18,642
13,366
32,049
20,336
Supply Chain Services
5,229
5,823
10,792
11,085
Total Segments Operating Income
$
74,042
$
63,044
$
140,056
$
115,596
RECONCILIATION OF OPERATING INCOME FOR REPORTABLE SEGMENTS($ thousands, unaudited)
Three Months Ended June 30,
Six Months Ended June 30,
2025
2024
2025
2024
Income from operations for reportable segments
$
74,042
$
63,044
$
140,056
$
115,596
Adjustment for:
Amortization of intangibles
5,327
4,719
10,684
9,088
Corporate expenses
22,729
20,973
42,871
40,025
Income from operations
$
45,986
$
37,352
$
86,501
$
66,483
Interest expense
14,744
15,384
29,404
30,928
Other income, net
(354
)
(1,035
)
(1,672
)
(3,004
)
Income before income taxes
$
31,596
$
23,003
$
58,769
$
38,559
RECONCILIATION OF NON-GAAP FINANCIAL INFORMATION($ thousands, unaudited)
We define and calculate EBITDA as Net income attributable to DXP Enterprises, Inc., plus interest, taxes, depreciation, and amortization. We define and calculate Adjusted EBITDA as Net income attributable to DXP Enterprises, Inc., plus interest, taxes, depreciation, and amortization minus stock-based compensation expense and all other non-cash charges, adjustments, and non-recurring items. We identify the impact of all other non-cash charges, adjustments and non-recurring items because we believe these items do not directly reflect our underlying operations.
We define and calculate EBITDA Margin as EBITDA divided by sales. We define and calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by sales.
The following table sets forth the reconciliation of EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin to the most comparable U.S. GAAP financial measure (in thousands):
Three Months Ended June 30,
Six Months Ended June 30,
2025
2024
2025
2024
Income before income taxes
$
31,596
$
23,003
$
58,769
$
38,559
Plus: Interest expense
14,744
15,384
29,404
30,928
Plus: Depreciation and amortization
9,490
8,127
18,624
15,665
EBITDA
$
55,830
$
46,514
$
106,797
$
85,152
Plus: other non-recurring items(1)
—
500
235
1,342
Plus: stock compensation expense
1,483
1,212
2,800
2,076
Adjusted EBITDA
$
57,313
$
48,226
$
109,832
$
88,570
Operating Income Margin
9.2
%
8.4
%
8.9
%
7.7
%
Net Income Margin
4.7
%
3.7
%
4.5
%
3.3
%
EBITDA Margin
11.2
%
10.4
%
11.0
%
9.9
%
Adjusted EBITDA Margin
11.5
%
10.8
%
11.3
%
10.3
%
(1) Other non-recurring items includes unique acquisition integration costs and other non-cash, non-recurring costs not related to continuing business operations.
We define and calculate organic sales to include locations and acquisitions under our ownership for at least twelve months. "Acquisition Sales" are sales from acquisitions that have been under our ownership for less than twelve months and are excluded in our calculation of Organic Sales.
"Business Days" are days of the week, excluding Saturdays, Sundays, and holidays, that our locations are open during the year. Depending on the location and the season, our branches may be open on Saturdays and Sundays; however, for consistency, those days have been excluded from the calculation of Business Days.
We define and calculate Sales per Business Day as sales divided by the number of Business Days in the relevant reporting period.
We define and calculate Organic Sales per Business Day as Organic Sales divided by the number of Business Days in the relevant reporting period.
The following table sets forth the reconciliation of Acquisition Sales, Organic Sales and Organic Sales per Business Day to the most comparable U.S. GAAP financial measure (in thousands):
Three Months Ended June 30,
Six Months Ended June 30,
2025
2024
2025
2024
Sales by Business Segment
Service Centers
$
339,731
$
306,516
$
666,806
$
594,952
Innovative Pumping Solutions
93,540
73,377
179,722
135,592
Supply Chain Services
65,411
65,663
128,723
127,647
Total DXP Sales
$
498,682
$
445,556
$
975,251
$
858,191
Acquisition Sales
$
24,605
$
23,403
$
55,717
$
35,178
Organic Sales
$
474,077
$
422,153
$
919,534
$
823,013
Business Days
63
64
126
127
Sales per Business Day
$
7,916
$
6,962
$
7,740
$
6,757
Organic Sales per Business Day
$
7,525
$
6,596
$
7,298
$
6,480
We define and calculate free cash flow as net cash (used in) provided by operating activities less purchases of property and equipment.
The following table sets forth the reconciliation of Free Cash Flow to the most comparable GAAP financial measure (in thousands):
Three Months Ended June 30,
Six Months Ended June 30,
2025
2024
2025
2024
Net cash from operating activities
$
18,646
$
14,735
$
21,619
$
41,724
Less: purchases of property and equipment
(10,346
)
(8,825
)
(30,260
)
(11,719
)
Free Cash Flow
$
8,300
$
5,910
$
(8,641
)
$
30,005
View source version on businesswire.com: https://www.businesswire.com/news/home/20250806825530/en/
Contacts
Kent YeeSenior Vice President, CFO713-996-4700www.dxpe.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Exact Sciences to acquire US rights for Freenome's blood-based CRC test
Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based colorectal cancer (CRC) screening test in the US. Exact Sciences plans to accelerate the market adoption of the CRC blood test by leveraging its commercial infrastructure. Under the agreement, Exact Sciences will pay Freenome an upfront cash payment of $75m that is payable by this November. Freenome is set to receive up to an additional $700m, contingent upon reaching specific milestones related to its CRC screening tests. These milestones include a $100m payment upon receiving first-line approval from the Food and Drug Administration (FDA) for their inaugural test and another $100m for the approval of a subsequent, next-generation test that meets or exceeds certain performance criteria, such as a minimum of 19% advanced precancerous lesions (APL) sensitivity and 83% overall CRC sensitivity. However, should the performance fall below these benchmarks, the payment would be adjusted accordingly. Furthermore, Freenome could earn $500m if its test is classified as a first-line A or B test in the US Preventive Services Taskforce (USPSTF) guidelines or if it achieves certain payer-contracted coverage requirements. Again, a decreased payment is applicable if the test is included in the USPSTF guidelines as a second-line A or B test. Freenome could be entitled to obtain royalties that vary between 0% and 10%, depending on the profitability of the test, while also adhering to standard provisions for royalty stacking. However, if specific conditions are not fulfilled, Exact Sciences reserves the right to end the agreement. Exact Sciences noted that it is committed to investing $20m annually over three years in joint research and development to further utilise the technology. Freenome retains rights to its CRC blood test when combined with other cancer screening tests. The license agreement also includes a senior convertible note purchase by Exact Sciences, amounting to $50m, with a coupon rate of 5% due in 2030. Freenome's PREEMPT CRC Study, which involved nearly 49,000 adults at average risk, demonstrated the CRC test's ability to identify 81.1% of CRC, including 63.5% at stage one, and 13.7% of APL, with a specificity of 90.4%. Freenome is also working on an 'improved version' of the test, which has shown enhanced performance in detection rates, and plans to submit a supplemental premarket approval application to the FDA once final clinical validation data are available. In a recent development, Exact Sciences expanded its collaboration with private insurer Humana to make the Cologuard Plus test available to eligible Humana Medicare Advantage members as an in-network service across the US. "Exact Sciences to acquire US rights for Freenome's blood-based CRC test" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
NiCE Provides Webcast and Dial-in Details for its Second Quarter 2025 Results Teleconference
HOBOKEN, N.J., August 07, 2025--(BUSINESS WIRE)--NiCE (Nasdaq: NICE) will announce its second quarter 2025 results on Thursday, August 14, 2025, before the opening of the NASDAQ Stock Exchange. Later that day, management will host a conference call to discuss the results. 8:30 AM - Eastern1:30 PM - UK3:30 PM - Israel The call will be webcast live on the Company's website at Please register with the relevant link for either the webcast or dial-in on our "upcoming event page." Kind Regards,NiCE Investor Relations About NiCENiCE (NASDAQ: NICE) is transforming the world with AI that puts people first. Our purpose-built AI-powered platforms automate engagements into proactive, safe, intelligent actions, empowering individuals and organizations to innovate and act, from interaction to resolution. Trusted by organizations throughout 150+ countries worldwide, NiCE's platforms are widely adopted across industries connecting people, systems, and workflows to work smarter at scale, elevating performance across the organization, delivering proven measurable outcomes. Trademark Note: NiCE and the NiCE logo are trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE's marks, please see: View source version on Contacts Investor Relations Contact Marty Cohen, +1-551-256-5354, ir@ ETOmri Arens, +972-3-763-0127, ir@ CET Corporate Media Contact Christopher Irwin-Dudek, 201-561-4442, media@ ET Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
Historic transfer: Son Heung-min signs with Los Angeles until 2027
MLS: Son Heung-min joins Los Angeles FC for two seasons! Son Heung-min / @ After intense negotiations, the American club Los Angeles has officially announced the signing of South Korean superstar Son Heung-min from Tottenham. This transfer becomes the most expensive in Major League Soccer history. At 33 years old, Son has signed a contract running until the end of 2027. The American club reached an agreement with Tottenham to buy out the remainder of the player's contract for $26 million, surpassing the previous record held by Ivorian Emmanuel Lâté ($22 million). Tottenham expressed its gratitude to their Korean international on the platform (X): "We can never thank you enough, Sonny." This transfer marks the end of a decade at the "Spurs" for Son, who played 454 matches and scored 173 goals, highlighted by the Europa League triumph last May. Son's final match in Tottenham colors took place against Newcastle United, during a friendly played in South Korea on August 3, which ended in a 1-1 draw.